메뉴 건너뛰기




Volumn 44, Issue 16, 2011, Pages 1278-1279

Protein fingerprints - Relying on and understanding the information of serological protein measurements

Author keywords

Biochemical marker; Extracellular matrix; FDA; Fingerprint; Neo epitope; Protein

Indexed keywords

BIOCHEMICAL MARKER; COLLAGEN TYPE 1; HEMOGLOBIN A1C;

EID: 80054085615     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.08.1135     Document Type: Editorial
Times cited : (53)

References (36)
  • 1
    • 77953718011 scopus 로고    scopus 로고
    • A novel assay for extracellular matrix remodeling associated with liver fibrosis: an enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen
    • Barascuk N., Veidal S.S., Larsen L., Larsen D.V., Larsen M.R., Wang J., et al. A novel assay for extracellular matrix remodeling associated with liver fibrosis: an enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clin Biochem 2010, 43:899-904.
    • (2010) Clin Biochem , vol.43 , pp. 899-904
    • Barascuk, N.1    Veidal, S.S.2    Larsen, L.3    Larsen, D.V.4    Larsen, M.R.5    Wang, J.6
  • 2
    • 0030891983 scopus 로고    scopus 로고
    • Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage
    • Billinghurst R.C., Dahlberg L., Ionescu M., Reiner A., Bourne R., Rorabeck C., et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997, 99:1534-1545.
    • (1997) J Clin Invest , vol.99 , pp. 1534-1545
    • Billinghurst, R.C.1    Dahlberg, L.2    Ionescu, M.3    Reiner, A.4    Bourne, R.5    Rorabeck, C.6
  • 3
    • 3442898781 scopus 로고    scopus 로고
    • Post-translational modifications of proteins: implications for aging, antigen recognition, and autoimmunity
    • Cloos P.A., Christgau S. Post-translational modifications of proteins: implications for aging, antigen recognition, and autoimmunity. Biogerontology 2004, 5:139-158.
    • (2004) Biogerontology , vol.5 , pp. 139-158
    • Cloos, P.A.1    Christgau, S.2
  • 4
    • 0034141218 scopus 로고    scopus 로고
    • Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential
    • Cloos P.A., Fledelius C. Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential. Biochem J 2000, 345(Pt 3):473-480.
    • (2000) Biochem J , vol.345 , Issue.PART 3 , pp. 473-480
    • Cloos, P.A.1    Fledelius, C.2
  • 5
    • 3042730990 scopus 로고    scopus 로고
    • An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone
    • Cloos P.A., Lyubimova N., Solberg H., Qvist P., Christiansen C., Byrjalsen I., et al. An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone. Clin Lab 2004, 50:279-289.
    • (2004) Clin Lab , vol.50 , pp. 279-289
    • Cloos, P.A.1    Lyubimova, N.2    Solberg, H.3    Qvist, P.4    Christiansen, C.5    Byrjalsen, I.6
  • 6
    • 0026720343 scopus 로고
    • Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma
    • Elomaa I., Virkkunen P., Risteli L., Risteli J. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer 1992, 66:337-341.
    • (1992) Br J Cancer , vol.66 , pp. 337-341
    • Elomaa, I.1    Virkkunen, P.2    Risteli, L.3    Risteli, J.4
  • 7
    • 0029085839 scopus 로고
    • Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids
    • Fosang A.J., Last K., Gardiner P., Jackson D.C., Brown L. Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids. Biochem J 1995, 310(Pt 1):337-343.
    • (1995) Biochem J , vol.310 , Issue.PART 1 , pp. 337-343
    • Fosang, A.J.1    Last, K.2    Gardiner, P.3    Jackson, D.C.4    Brown, L.5
  • 8
    • 0029852094 scopus 로고    scopus 로고
    • Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent
    • Fosang A.J., Last K., Maciewicz R.A. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent. J Clin Invest 1996, 98:2292-2299.
    • (1996) J Clin Invest , vol.98 , pp. 2292-2299
    • Fosang, A.J.1    Last, K.2    Maciewicz, R.A.3
  • 9
    • 10744225319 scopus 로고    scopus 로고
    • The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation
    • Garnero P., Ferreras M., Karsdal M.A., NicAmhlaoibh R., Risteli J., Borel O., et al. The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res 2003, 18:859-867.
    • (2003) J Bone Miner Res , vol.18 , pp. 859-867
    • Garnero, P.1    Ferreras, M.2    Karsdal, M.A.3    NicAmhlaoibh, R.4    Risteli, J.5    Borel, O.6
  • 10
    • 15844413814 scopus 로고    scopus 로고
    • Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis
    • Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H.L., et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005, 434:644-648.
    • (2005) Nature , vol.434 , pp. 644-648
    • Glasson, S.S.1    Askew, R.2    Sheppard, B.3    Carito, B.4    Blanchet, T.5    Ma, H.L.6
  • 11
    • 4043154293 scopus 로고    scopus 로고
    • Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice
    • Glasson S.S., Askew R., Sheppard B., Carito B.A., Blanchet T., Ma H.L., et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum 2004, 50:2547-2558.
    • (2004) Arthritis Rheum , vol.50 , pp. 2547-2558
    • Glasson, S.S.1    Askew, R.2    Sheppard, B.3    Carito, B.A.4    Blanchet, T.5    Ma, H.L.6
  • 12
    • 29644437921 scopus 로고    scopus 로고
    • Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification
    • Henriksen K., Sorensen M.G., Nielsen Rh., Gram J., Schaller S., Dziegiel M.H., et al. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification. J Bone Miner Res 2006, 21:58-66.
    • (2006) J Bone Miner Res , vol.21 , pp. 58-66
    • Henriksen, K.1    Sorensen, M.G.2    Nielsen, R.3    Gram, J.4    Schaller, S.5    Dziegiel, M.H.6
  • 13
    • 66149103673 scopus 로고    scopus 로고
    • Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development
    • Karsdal M.A., Henriksen K., Leeming D.J., Mitchell P., Duffin K., Barascuk N., et al. Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development. Biomarkers 2009, 14:181-202.
    • (2009) Biomarkers , vol.14 , pp. 181-202
    • Karsdal, M.A.1    Henriksen, K.2    Leeming, D.J.3    Mitchell, P.4    Duffin, K.5    Barascuk, N.6
  • 14
    • 77953706518 scopus 로고    scopus 로고
    • Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers-are they the cause or the consequence of the disease?
    • Karsdal M.A., Henriksen K., Leeming D.J., Woodworth T., Vassiliadis E., Bay-Jensen A.C. Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers-are they the cause or the consequence of the disease?. Clin Biochem 2010, 43:793-804.
    • (2010) Clin Biochem , vol.43 , pp. 793-804
    • Karsdal, M.A.1    Henriksen, K.2    Leeming, D.J.3    Woodworth, T.4    Vassiliadis, E.5    Bay-Jensen, A.C.6
  • 18
    • 77956775667 scopus 로고    scopus 로고
    • Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP)-assessment of corresponding epitopes
    • Leeming D.J., Larsen D.V., Zhang C., Hi Y., Veidal S.S., Nielsen Rh., et al. Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP)-assessment of corresponding epitopes. Clin Biochem 2010, 43:1249-1256.
    • (2010) Clin Biochem , vol.43 , pp. 1249-1256
    • Leeming, D.J.1    Larsen, D.V.2    Zhang, C.3    Hi, Y.4    Veidal, S.S.5    Nielsen, R.6
  • 19
    • 0032714266 scopus 로고    scopus 로고
    • Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation
    • Nishi Y., Atley L., Eyre D.E., Edelson J.G., Superti-Furga A., Yasuda T., et al. Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation. J Bone Miner Res 1999, 14:1902-1908.
    • (1999) J Bone Miner Res , vol.14 , pp. 1902-1908
    • Nishi, Y.1    Atley, L.2    Eyre, D.E.3    Edelson, J.G.4    Superti-Furga, A.5    Yasuda, T.6
  • 20
    • 41849121543 scopus 로고    scopus 로고
    • Novel splice variants of prostate-specific antigen and applications in diagnosis of prostate cancer
    • Pampalakis G., Scorilas A., Sotiropoulou G. Novel splice variants of prostate-specific antigen and applications in diagnosis of prostate cancer. Clin Biochem 2008, 41:591-597.
    • (2008) Clin Biochem , vol.41 , pp. 591-597
    • Pampalakis, G.1    Scorilas, A.2    Sotiropoulou, G.3
  • 21
    • 78149501151 scopus 로고    scopus 로고
    • Performance characteristics of an automated assay for the quantitation of CYFRA 21-1 in human serum
    • Patel J.L., Erickson J.A., Roberts W.L., Grenache D.G. Performance characteristics of an automated assay for the quantitation of CYFRA 21-1 in human serum. Clin Biochem 2010, 43:1449-1452.
    • (2010) Clin Biochem , vol.43 , pp. 1449-1452
    • Patel, J.L.1    Erickson, J.A.2    Roberts, W.L.3    Grenache, D.G.4
  • 22
    • 0033105942 scopus 로고    scopus 로고
    • Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women, Alendronate Osteoporosis Prevention Study Group
    • Ravn P., Clemmesen B., Christiansen C. Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women, Alendronate Osteoporosis Prevention Study Group. Bone 1999, 24:237-244.
    • (1999) Bone , vol.24 , pp. 237-244
    • Ravn, P.1    Clemmesen, B.2    Christiansen, C.3
  • 23
    • 0033306407 scopus 로고    scopus 로고
    • Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study
    • Ravn P., Hosking D., Thompson D., Cizza G., Wasnich R.D., McClung M., et al. Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study. J Clin Endocrinol Metab 1999, 84:2363-2368.
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 2363-2368
    • Ravn, P.1    Hosking, D.2    Thompson, D.3    Cizza, G.4    Wasnich, R.D.5    McClung, M.6
  • 24
    • 0031786307 scopus 로고    scopus 로고
    • Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen
    • Rosenquist C., Fledelius C., Christgau S., Pedersen B.J., Bonde M., Qvist P., et al. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem 1998, 44:2281-2289.
    • (1998) Clin Chem , vol.44 , pp. 2281-2289
    • Rosenquist, C.1    Fledelius, C.2    Christgau, S.3    Pedersen, B.J.4    Bonde, M.5    Qvist, P.6
  • 25
    • 0034012685 scopus 로고    scopus 로고
    • Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K
    • Sassi M.L., Eriksen H., Risteli L., Niemi S., Mansell J., Gowen M., et al. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K. Bone 2000, 26:367-373.
    • (2000) Bone , vol.26 , pp. 367-373
    • Sassi, M.L.1    Eriksen, H.2    Risteli, L.3    Niemi, S.4    Mansell, J.5    Gowen, M.6
  • 26
    • 29244440826 scopus 로고    scopus 로고
    • In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: how biomarkers can assist?
    • Schaller S., Henriksen K., Hoegh-Andersen P., Sondergaard B.C., Sumer E.U., Tanko L.B., et al. In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: how biomarkers can assist?. Assay Drug Dev Technol 2005, 3:553-580.
    • (2005) Assay Drug Dev Technol , vol.3 , pp. 553-580
    • Schaller, S.1    Henriksen, K.2    Hoegh-Andersen, P.3    Sondergaard, B.C.4    Sumer, E.U.5    Tanko, L.B.6
  • 27
    • 77953726007 scopus 로고    scopus 로고
    • Identification of a complex between fibronectin and aggrecan G3 domain in synovial fluid of patients with painful meniscal pathology
    • Scuderi G.J., Woolf N., Dent K., Golish S.R., Cuellar J.M., Cuellar V.G., et al. Identification of a complex between fibronectin and aggrecan G3 domain in synovial fluid of patients with painful meniscal pathology. Clin Biochem 2010, 43:808-814.
    • (2010) Clin Biochem , vol.43 , pp. 808-814
    • Scuderi, G.J.1    Woolf, N.2    Dent, K.3    Golish, S.R.4    Cuellar, J.M.5    Cuellar, V.G.6
  • 28
    • 0034931888 scopus 로고    scopus 로고
    • Carboxyterminal telopeptide of type I collagen (ICTP) in predicting prognosis in epithelial ovarian cancer
    • Simojoki M., Santala M., Risteli J., Kauppila A. Carboxyterminal telopeptide of type I collagen (ICTP) in predicting prognosis in epithelial ovarian cancer. Gynecol Oncol 2001, 82:110-115.
    • (2001) Gynecol Oncol , vol.82 , pp. 110-115
    • Simojoki, M.1    Santala, M.2    Risteli, J.3    Kauppila, A.4
  • 29
    • 15844384854 scopus 로고    scopus 로고
    • ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro
    • Stanton H., Rogerson F.M., East C.J., Golub S.B., Lawlor K.E., Meeker C.T., et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 2005, 434:648-652.
    • (2005) Nature , vol.434 , pp. 648-652
    • Stanton, H.1    Rogerson, F.M.2    East, C.J.3    Golub, S.B.4    Lawlor, K.E.5    Meeker, C.T.6
  • 30
    • 79151473054 scopus 로고    scopus 로고
    • Measurement of B-type natriuretic peptide by two assays utilizing antibodies with different epitope specificity
    • Tamm N.N., Semenov A.G., Seferian K.R., Bereznikova A.V., Murakami M.M., Apple F.S., et al. Measurement of B-type natriuretic peptide by two assays utilizing antibodies with different epitope specificity. Clin Biochem 2011, 44:257-259.
    • (2011) Clin Biochem , vol.44 , pp. 257-259
    • Tamm, N.N.1    Semenov, A.G.2    Seferian, K.R.3    Bereznikova, A.V.4    Murakami, M.M.5    Apple, F.S.6
  • 31
    • 69249220091 scopus 로고    scopus 로고
    • A novel ultra-sensitive enzyme immunoassay for soluble human insulin receptor ectodomain and its measurement in urine from healthy subjects and patients with diabetes mellitus
    • Umehara A., Nishioka M., Obata T., Ebina Y., Shiota H., Hashida S. A novel ultra-sensitive enzyme immunoassay for soluble human insulin receptor ectodomain and its measurement in urine from healthy subjects and patients with diabetes mellitus. Clin Biochem 2009, 42:1468-1475.
    • (2009) Clin Biochem , vol.42 , pp. 1468-1475
    • Umehara, A.1    Nishioka, M.2    Obata, T.3    Ebina, Y.4    Shiota, H.5    Hashida, S.6
  • 32
    • 77249095861 scopus 로고    scopus 로고
    • Serum markers of liver fibrosis: combining the BIPED classification and the neo-epitope approach in the development of new biomarkers
    • Veidal S.S., Bay-Jensen A.C., Tougas G., Karsdal M.A., Vainer B. Serum markers of liver fibrosis: combining the BIPED classification and the neo-epitope approach in the development of new biomarkers. Dis Markers 2010, 28:15-28.
    • (2010) Dis Markers , vol.28 , pp. 15-28
    • Veidal, S.S.1    Bay-Jensen, A.C.2    Tougas, G.3    Karsdal, M.A.4    Vainer, B.5
  • 33
    • 79151469549 scopus 로고    scopus 로고
    • Application of serum protein fingerprint in diagnosis of coronary artery disease
    • Wang Y., Hu X., Wang J.A., Xiang M., Yu J., Liu F., et al. Application of serum protein fingerprint in diagnosis of coronary artery disease. Clin Biochem 2011, 44:185-191.
    • (2011) Clin Biochem , vol.44 , pp. 185-191
    • Wang, Y.1    Hu, X.2    Wang, J.A.3    Xiang, M.4    Yu, J.5    Liu, F.6
  • 34
    • 0034901276 scopus 로고    scopus 로고
    • Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer
    • Ylisirnio S., Hoyhtya M., Makitaro R., Paaakko P., Risteli J., Kinnula V.L., et al. Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer. Clin Cancer Res 2001, 7:1633-1637.
    • (2001) Clin Cancer Res , vol.7 , pp. 1633-1637
    • Ylisirnio, S.1    Hoyhtya, M.2    Makitaro, R.3    Paaakko, P.4    Risteli, J.5    Kinnula, V.L.6
  • 35
    • 0033390826 scopus 로고    scopus 로고
    • Serum type I collagen degradation markers, ICTP and CrossLaps, are factors for poor survival in lung cancer
    • Ylisirnio S., Sassi M.L., Risteli J., Turpeenniemi-Hujanen T., Jukkola A. Serum type I collagen degradation markers, ICTP and CrossLaps, are factors for poor survival in lung cancer. Anticancer Res 1999, 19:5577-5581.
    • (1999) Anticancer Res , vol.19 , pp. 5577-5581
    • Ylisirnio, S.1    Sassi, M.L.2    Risteli, J.3    Turpeenniemi-Hujanen, T.4    Jukkola, A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.